{"id":446,"date":"2020-07-15T23:13:51","date_gmt":"2020-07-15T23:13:51","guid":{"rendered":"https:\/\/artemisresearc.wpengine.com\/?p=446"},"modified":"2026-04-07T09:01:56","modified_gmt":"2026-04-07T09:01:56","slug":"fda-approves-eisais-dayvigo-for-insomnia-treatment","status":"publish","type":"post","link":"https:\/\/artemis-research.com\/es\/fda-approves-eisais-dayvigo-for-insomnia-treatment\/","title":{"rendered":"LA FDA aprueba DayVigo de Eisai Para Tratar el  Insomnio"},"content":{"rendered":"<p>La FDA de los EE.UU. aprueba DayVigo (Lemborexant) de Eisai para el tratamiento del insomnio en pacientes adultos! La FDA aprob\u00f3 la nueva solicitud de f\u00e1rmaco para el antagonista del receptor de orexina DayVigo (lemborexant), descubierto y desarrollado internamente. DayVigo fue aprobado para el tratamiento del insomnio caracterizado por dificultades con el inicio del sue\u00f1o y \/ o el mantenimiento del sue\u00f1o en adultos. En los Estados Unidos, DayVigo estar\u00e1 disponible comercialmente en tabletas de 5 mg y 10 mg despu\u00e9s de la programaci\u00f3n de la Administraci\u00f3n de Control de Drogas de los Estados Unidos (DEA), que se espera que ocurra dentro de 90 d\u00edas.<\/p>\n<p class=\"translation-block\">Para obtener m\u00e1s informaci\u00f3n sobre los resultados de este estudio y el nuevo medicamento aprobado, haga <a href=\"https:\/\/www.eisai.com\/news\/2019\/news201993.html\" target=\"_self\">clic aqu\u00ed<\/a>.<\/p>\n<!-- AddThis Advanced Settings generic via filter on the_content --><!-- AddThis Share Buttons generic via filter on the_content -->","protected":false},"excerpt":{"rendered":"<p>U.S. FDA approves Eisai\u2019s DayVigo (Lemborexant) for the treatment of insomnia in adult patients! The FDA approved the new drug application for its in-house discovered and developed orexin receptor antagonist DayVigo (lemborexant). DayVigo was &#8230; <a class=\"read-more\" title=\"FULL STORY\" href=\"https:\/\/artemis-research.com\/es\/fda-approves-eisais-dayvigo-for-insomnia-treatment\/\">Ver Mas<\/a><!-- AddThis Advanced Settings generic via filter on get_the_excerpt --><!-- AddThis Share Buttons generic via filter on get_the_excerpt --><\/p>","protected":false},"author":16,"featured_media":447,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[5],"tags":[],"class_list":{"0":"post-446","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-news-and-events","8":"entry"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FDA approves Eisai\u2019s DayVigo for insomnia treatment - Artemis Institute for Clinical Research<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/artemis-research.com\/es\/fda-approves-eisais-dayvigo-for-insomnia-treatment\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA approves Eisai\u2019s DayVigo for insomnia treatment - Artemis Institute for Clinical Research\" \/>\n<meta property=\"og:description\" content=\"U.S. FDA approves Eisai\u2019s DayVigo (Lemborexant) for the treatment of insomnia in adult patients! The FDA approved the new drug application for its in-house discovered and developed orexin receptor antagonist DayVigo (lemborexant). DayVigo was ... Read More\" \/>\n<meta property=\"og:url\" content=\"https:\/\/artemis-research.com\/es\/fda-approves-eisais-dayvigo-for-insomnia-treatment\/\" \/>\n<meta property=\"og:site_name\" content=\"Artemis Institute for Clinical Research\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-15T23:13:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-07T09:01:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/artemis-research.com\/wp-content\/uploads\/2020\/07\/Eisai_DayVigo-e1594854817249.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"411\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Brittany Buckley\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brittany Buckley\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/artemis-research.com\\\/fda-approves-eisais-dayvigo-for-insomnia-treatment\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/artemis-research.com\\\/fda-approves-eisais-dayvigo-for-insomnia-treatment\\\/\"},\"author\":{\"name\":\"Brittany Buckley\",\"@id\":\"https:\\\/\\\/artemis-research.com\\\/es\\\/#\\\/schema\\\/person\\\/fa7951c4a5f8f204702efc30b6f8fa7e\"},\"headline\":\"FDA approves Eisai\u2019s DayVigo for insomnia treatment\",\"datePublished\":\"2020-07-15T23:13:51+00:00\",\"dateModified\":\"2026-04-07T09:01:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/artemis-research.com\\\/fda-approves-eisais-dayvigo-for-insomnia-treatment\\\/\"},\"wordCount\":109,\"image\":{\"@id\":\"https:\\\/\\\/artemis-research.com\\\/fda-approves-eisais-dayvigo-for-insomnia-treatment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/artemis-research.com\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/Eisai_DayVigo-e1594854817249.png\",\"articleSection\":[\"News and Events\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/artemis-research.com\\\/fda-approves-eisais-dayvigo-for-insomnia-treatment\\\/\",\"url\":\"https:\\\/\\\/artemis-research.com\\\/fda-approves-eisais-dayvigo-for-insomnia-treatment\\\/\",\"name\":\"FDA approves Eisai\u2019s DayVigo for insomnia treatment - Artemis Institute for Clinical Research\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/artemis-research.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/artemis-research.com\\\/fda-approves-eisais-dayvigo-for-insomnia-treatment\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/artemis-research.com\\\/fda-approves-eisais-dayvigo-for-insomnia-treatment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/artemis-research.com\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/Eisai_DayVigo-e1594854817249.png\",\"datePublished\":\"2020-07-15T23:13:51+00:00\",\"dateModified\":\"2026-04-07T09:01:56+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/artemis-research.com\\\/es\\\/#\\\/schema\\\/person\\\/fa7951c4a5f8f204702efc30b6f8fa7e\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/artemis-research.com\\\/fda-approves-eisais-dayvigo-for-insomnia-treatment\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/artemis-research.com\\\/fda-approves-eisais-dayvigo-for-insomnia-treatment\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/artemis-research.com\\\/fda-approves-eisais-dayvigo-for-insomnia-treatment\\\/#primaryimage\",\"url\":\"https:\\\/\\\/artemis-research.com\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/Eisai_DayVigo-e1594854817249.png\",\"contentUrl\":\"https:\\\/\\\/artemis-research.com\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/Eisai_DayVigo-e1594854817249.png\",\"width\":800,\"height\":411},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/artemis-research.com\\\/fda-approves-eisais-dayvigo-for-insomnia-treatment\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/artemis-research.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA approves Eisai\u2019s DayVigo for insomnia treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/artemis-research.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/artemis-research.com\\\/es\\\/\",\"name\":\"Artemis Institute for Clinical Research\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/artemis-research.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/artemis-research.com\\\/es\\\/#\\\/schema\\\/person\\\/fa7951c4a5f8f204702efc30b6f8fa7e\",\"name\":\"Brittany Buckley\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/11028d2a97555e7ab0eed9757df88cd584e21b3bb32347d73b6be68e79458e09?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/11028d2a97555e7ab0eed9757df88cd584e21b3bb32347d73b6be68e79458e09?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/11028d2a97555e7ab0eed9757df88cd584e21b3bb32347d73b6be68e79458e09?s=96&d=mm&r=g\",\"caption\":\"Brittany Buckley\"},\"url\":\"https:\\\/\\\/artemis-research.com\\\/es\\\/author\\\/brittany-buckley\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDA approves Eisai\u2019s DayVigo for insomnia treatment - Artemis Institute for Clinical Research","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/artemis-research.com\/es\/fda-approves-eisais-dayvigo-for-insomnia-treatment\/","og_locale":"es_MX","og_type":"article","og_title":"FDA approves Eisai\u2019s DayVigo for insomnia treatment - Artemis Institute for Clinical Research","og_description":"U.S. FDA approves Eisai\u2019s DayVigo (Lemborexant) for the treatment of insomnia in adult patients! The FDA approved the new drug application for its in-house discovered and developed orexin receptor antagonist DayVigo (lemborexant). DayVigo was ... Read More","og_url":"https:\/\/artemis-research.com\/es\/fda-approves-eisais-dayvigo-for-insomnia-treatment\/","og_site_name":"Artemis Institute for Clinical Research","article_published_time":"2020-07-15T23:13:51+00:00","article_modified_time":"2026-04-07T09:01:56+00:00","og_image":[{"width":800,"height":411,"url":"https:\/\/artemis-research.com\/wp-content\/uploads\/2020\/07\/Eisai_DayVigo-e1594854817249.png","type":"image\/png"}],"author":"Brittany Buckley","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Brittany Buckley","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/artemis-research.com\/fda-approves-eisais-dayvigo-for-insomnia-treatment\/#article","isPartOf":{"@id":"https:\/\/artemis-research.com\/fda-approves-eisais-dayvigo-for-insomnia-treatment\/"},"author":{"name":"Brittany Buckley","@id":"https:\/\/artemis-research.com\/es\/#\/schema\/person\/fa7951c4a5f8f204702efc30b6f8fa7e"},"headline":"FDA approves Eisai\u2019s DayVigo for insomnia treatment","datePublished":"2020-07-15T23:13:51+00:00","dateModified":"2026-04-07T09:01:56+00:00","mainEntityOfPage":{"@id":"https:\/\/artemis-research.com\/fda-approves-eisais-dayvigo-for-insomnia-treatment\/"},"wordCount":109,"image":{"@id":"https:\/\/artemis-research.com\/fda-approves-eisais-dayvigo-for-insomnia-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/artemis-research.com\/wp-content\/uploads\/2020\/07\/Eisai_DayVigo-e1594854817249.png","articleSection":["News and Events"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/artemis-research.com\/fda-approves-eisais-dayvigo-for-insomnia-treatment\/","url":"https:\/\/artemis-research.com\/fda-approves-eisais-dayvigo-for-insomnia-treatment\/","name":"FDA approves Eisai\u2019s DayVigo for insomnia treatment - Artemis Institute for Clinical Research","isPartOf":{"@id":"https:\/\/artemis-research.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/artemis-research.com\/fda-approves-eisais-dayvigo-for-insomnia-treatment\/#primaryimage"},"image":{"@id":"https:\/\/artemis-research.com\/fda-approves-eisais-dayvigo-for-insomnia-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/artemis-research.com\/wp-content\/uploads\/2020\/07\/Eisai_DayVigo-e1594854817249.png","datePublished":"2020-07-15T23:13:51+00:00","dateModified":"2026-04-07T09:01:56+00:00","author":{"@id":"https:\/\/artemis-research.com\/es\/#\/schema\/person\/fa7951c4a5f8f204702efc30b6f8fa7e"},"breadcrumb":{"@id":"https:\/\/artemis-research.com\/fda-approves-eisais-dayvigo-for-insomnia-treatment\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/artemis-research.com\/fda-approves-eisais-dayvigo-for-insomnia-treatment\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/artemis-research.com\/fda-approves-eisais-dayvigo-for-insomnia-treatment\/#primaryimage","url":"https:\/\/artemis-research.com\/wp-content\/uploads\/2020\/07\/Eisai_DayVigo-e1594854817249.png","contentUrl":"https:\/\/artemis-research.com\/wp-content\/uploads\/2020\/07\/Eisai_DayVigo-e1594854817249.png","width":800,"height":411},{"@type":"BreadcrumbList","@id":"https:\/\/artemis-research.com\/fda-approves-eisais-dayvigo-for-insomnia-treatment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/artemis-research.com\/"},{"@type":"ListItem","position":2,"name":"FDA approves Eisai\u2019s DayVigo for insomnia treatment"}]},{"@type":"WebSite","@id":"https:\/\/artemis-research.com\/es\/#website","url":"https:\/\/artemis-research.com\/es\/","name":"Artemis Institute for Clinical Research","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/artemis-research.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/artemis-research.com\/es\/#\/schema\/person\/fa7951c4a5f8f204702efc30b6f8fa7e","name":"Brittany Buckley","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/11028d2a97555e7ab0eed9757df88cd584e21b3bb32347d73b6be68e79458e09?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/11028d2a97555e7ab0eed9757df88cd584e21b3bb32347d73b6be68e79458e09?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11028d2a97555e7ab0eed9757df88cd584e21b3bb32347d73b6be68e79458e09?s=96&d=mm&r=g","caption":"Brittany Buckley"},"url":"https:\/\/artemis-research.com\/es\/author\/brittany-buckley\/"}]}},"jetpack_featured_media_url":"https:\/\/artemis-research.com\/wp-content\/uploads\/2020\/07\/Eisai_DayVigo-e1594854817249.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/artemis-research.com\/es\/wp-json\/wp\/v2\/posts\/446","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/artemis-research.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/artemis-research.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/artemis-research.com\/es\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/artemis-research.com\/es\/wp-json\/wp\/v2\/comments?post=446"}],"version-history":[{"count":1,"href":"https:\/\/artemis-research.com\/es\/wp-json\/wp\/v2\/posts\/446\/revisions"}],"predecessor-version":[{"id":872,"href":"https:\/\/artemis-research.com\/es\/wp-json\/wp\/v2\/posts\/446\/revisions\/872"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/artemis-research.com\/es\/wp-json\/wp\/v2\/media\/447"}],"wp:attachment":[{"href":"https:\/\/artemis-research.com\/es\/wp-json\/wp\/v2\/media?parent=446"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/artemis-research.com\/es\/wp-json\/wp\/v2\/categories?post=446"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/artemis-research.com\/es\/wp-json\/wp\/v2\/tags?post=446"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}